Link: https://www.reuters.

com/article/us-health-coronovirus-eu-vaccines/eu-
commission-to-end-astrazeneca-and-jj-vaccine-contracts-at-expiry-paper-
idUSKBN2C10MU

Words: 241 words

TOPIC: HEALTHCARE

APRIL 14, 2021 1:29 PM UPDATED 26 MINUTES AGO

EU Commission to end
AstraZeneca and J&J vaccine
contracts at expiry: paper
MILAN (Reuters) - The EU Commission has decided not to renew
COVID-19 vaccine contracts next year with AstraZeneca and Johnson &
Johnson (J&J), Italian daily La Stampa reported on Wednesday, citing a
source from the Italian health ministry.

“The European Commission, in agreement with the leaders of many

(EU) countries, has decided that the contracts with the companies that
produce (viral vector) vaccines that are valid for the current year will not
be renewed at their expiry,” the newspaper reported.

It added that Brussels would rather focus on COVID-19 vaccines using

messenger RNA (mRNA) technology, such as Pfizer’s and Moderna’s.

A spokesman for the EU Commission said it was keeping all options

open to be prepared for the next stages of the pandemic, for 2022 and
beyond.

“We cannot, however, comment on contractual issues,” the spokesman

added.
Later on Wednesday the President of the European Commission said the
EU was in talks with Pfizer and BionTech for a new contract for 1.8
billion doses, confirming a Reuters report from last week.

“We need to focus on technologies that have proven their worth. mRNA
vaccines are a clear case in point,” she added.

The Italian health ministry declined to comment.

The European Commission is seeking clarification from J&J about the

company’s “completely unexpected” announcement of delays in
COVID-19 vaccine deliveries to the EU, an EU official told Reuters on
Tuesday.

156 words
EU Commission to end
AstraZeneca and J&J
vaccine contracts at
expiry
The EU Commission has decided
not to renew COVID-19 vaccine
contracts next year with
AstraZeneca and Johnson &
Johnson (J&J), Italian daily La
Stampa reported on Wednesday,
citing a source from the Italian
health ministry.
The European Commission is
seeking clarification from J&J
about the company’s “completely
unexpected” announcement of
delays in COVID-19 vaccine
deliveries to the EU, an EU
official told Reuters on Tuesday.
Ủy ban EU không gia hạn
hợp đồng vắc xin
AstraZeneca và Johnson
& Johnson
Hôm thứ 4 (14/4), nhật báo La
Stampa của Ý trích dẫn một
nguồn tin từ Bộ Y Tế nước này
rằng Ủy ban EU quyết định không
gia hạn hợp đồng vắc xin COVID-
19 năm tới với AstraZeneca và
Johnson & Johnson.
Trước đó, hôm thứ 3 (13/4), một
quan chức EU trả lời hãng thông
tấn Reuters rằng Ủy ban EU đang
đợi J&J giải trình về thông báo
“không thể lường trước” của
công ty này về sự chậm trễ trong
việc hoàn tất giao vắc xin
COVID-19 cho EU.
“The European Commission, in
agreement with the leaders of
many (EU) countries, has decided
that the contracts with the
companies that produce (viral
vector) vaccines that are valid for
the current year will not be
renewed at their expiry,” the daily
La Stampa reported.
Later on Wednesday the President
of the European Commission said
the EU was in talks with Pfizer
and BionTech for a new contract
for 1.8 billion doses, confirming a
Reuters report from last week.
Nhật báo La Stampa của Ý đưa
tin: “Được sự đồng ý của các nhà
lãnh đạo của nhiều quốc gia trong
khối Liên minh châu Âu, Ủy ban
EU quyết định sẽ không gia hạn
hợp đồng (có hiệu lực trong năm
nay) với các công ty sản xuất vắc-
xin (véc-tơ vi-rút).
Hôm thứ 4 (14/4) vào cuối ngày,
Chủ tịch Ủy ban Châu Âu cho biết
EU đang đàm phán hợp đồng mới
với Pfizer và BionTech. Theo
nguồn tin của Reuters tuần trước,
thương vụ này được đàm phán cho
1,8 tỷ liều vắc xin COVID-19.